Theo van Voorthuizen

Author

Also Known As

A U G van Lent, Jeroen F. J. Vogelaar, Marija Trajkovic-Vidakovic, T van Voorthuizen, T. V. Voorthuizen, T. Van Voorthuizen, T. Voorthuizen, T. van Voorthuizen, Theo Van Voorthuizen, Theo van Voorthuizen

Publications

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Rijnstate Hospital Radboud University Medical Center University Medical Center Utrecht Amsterdam University Medical Centers

About

Theo van Voorthuizen is an author at Radboud University Nijmegen specializing in medicine, breast cancer, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	441
2	Health Sciences	1	1	12
3	Public Health	1	1	102
4	Anesthesia	1	1	12
5	Emergency Medicine	1	1	102

Theo van Voorthuizen

Publications

903

Citations

H-Index

Page 1

	Year	Citations
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial Vivianne C. G. Tjan‐Heijnen, Irene E.G. van Hellemond, Petronella G.M. Peer, The Lancet Oncology MedicineClinical TrialsGynecologyBreast CancerAromatase	2017	157
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld, The Lancet Oncology Surgical OncologyHepatologyMedicineHepatobiliary TumorColorectal Cancer	2023	153
Practical diagnostic management of patients with clinically suspected deep vein thrombosis by clinical probability test, compression ultrasonography, and D-dimer test Lidwine W. Tick, Evelien Ton, Theo van Voorthuizen, The American Journal of Medicine Compression UltrasonographyPulmonary EmbolismThrombosisPractical Diagnostic ManagementVenous Thrombosis	2002	102
Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group Johannes J.M. Kwakman, Lieke H. J. Simkens, Johan M. van Rooijen, Annals of Oncology	2017	81
Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer: A population-based study Seyed M. Qaderi, J. Van Der Heijden, Rob H.A. Verhoeven, European Journal of Cancer	2021	51
A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya Jeroen van Dillen, Martijn Custers, A. Wensink, Transactions of the Royal Society of Tropical Medicine and Hygiene	1999	45
Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real‐world evidence study Willemieke P.M. Dijksterhuis, Rob H.A. Verhoeven, Marije Slingerland, International Journal of Cancer	2019	44
Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin Joeri Dierks, Marcia P. Gaspersz, Ali Belkouz, Acta Oncologica	2017	31
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era G. Emerens Wensink, Marloes A.G. Elferink, Anne M. May, British Journal of Cancer	2020	25
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study Willemieke P.M. Dijksterhuis, Rob H.A. Verhoeven, Sybren L. Meijer, Gastric Cancer	2020	24

Page 1